ST36 acupoint injection with anisodamine for postoperative nausea and vomiting in female patients after bariatric surgery: a prospective, randomized controlled trial.

"Declarations DisclosuresDr. Qi Xue, Qijing Xing, Ling Dong, Min Guo, Xiaoyan Zhang, Xinchun Wei, Dr. Benli Jia, Prof. Yong Wang, Hong Chen, Prof. Xianwen Hu, Prof. Hong Liu, Prof. Ye Zhang, Prof. Gordon Tin Chun Wong, Dr. Chunxia Huang have no conflicts of interest or financial ties to disclose. Disclosures Dr. Qi Xue, Qijing Xing, Ling Dong, Min Guo, Xiaoyan Zhang, Xinchun Wei, Dr. Benli Jia, Prof. Yong Wang, Hong Chen, Prof. Xianwen Hu, Prof. Hong Liu, Prof. Ye Zhang, Prof. Gordon Tin Chun Wong, Dr. Chunxia Huang have no conflicts of interest or financial ties to disclose."

"Funding This study was supported by Basic and clinical cooperative research promotion plan of Anhui Medical University (Grant 2019xkjT026), the National Natural Science Foundation of China (Grant 81801050), Scientific Research Platform Base Construction and Promotion Project of Anhui Medical University (Grant 2020xkjT060), Key research and development program of Anhui Province (Grant 2022e07020048), and Scientific Research Fund of Anhui Medical University (Grant 2022xkj040)."

"This single-center prospective, randomised, double-blinded study was approved by the Ethics Committee of the Second Affiliated Hospital of Anhui Medical University, Anhui province, China (Chairperson Prof. Yanghua Tian) on December 2, 2021 (Ref YX2021-114) in accordance to the principles of the Declaration of Helsinki. The trial was registered in clinicaltrials.gov (NCT05240482) and carried out at the Second Affiliated Hospital of Anhui Medical University from 20 February to 6 July 2022. Written informed consent was obtained from all participants. The time period of this trial consisted of a 72-h follow-up after bariatric surgery in the hospital and a follow-up period of an additional 3 months after discharge."